251 related articles for article (PubMed ID: 2479050)
1. Prostatic carcinoma and benign prostatic hyperplasia: MR imaging with histopathologic correlation.
Kahn T; Bürrig K; Schmitz-Dräger B; Lewin JS; Fürst G; Mödder U
Radiology; 1989 Dec; 173(3):847-51. PubMed ID: 2479050
[TBL] [Abstract][Full Text] [Related]
2. [Magnetic resonance tomography of prostatic cancer. A histopathologic correlation].
Kahn T; Bürrig KF; Schmitz-Dräger B; Fürst G; Stork W; Mödder U
Radiologe; 1989 Mar; 29(3):144-9. PubMed ID: 2469100
[TBL] [Abstract][Full Text] [Related]
3. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings.
Schiebler ML; Tomaszewski JE; Bezzi M; Pollack HM; Kressel HY; Cohen EK; Altman HG; Gefter WB; Wein AJ; Axel L
Radiology; 1989 Jul; 172(1):131-7. PubMed ID: 2472644
[TBL] [Abstract][Full Text] [Related]
4. Prostatic carcinoma and benign prostatic hyperplasia: inability of MR imaging to distinguish between the two diseases.
Ling D; Lee JK; Heiken JP; Balfe DM; Glazer HS; McClennan BL
Radiology; 1986 Jan; 158(1):103-7. PubMed ID: 2416005
[TBL] [Abstract][Full Text] [Related]
5. The abnormal prostate: MR imaging at 1.5 T with histopathologic correlation.
Carrol CL; Sommer FG; McNeal JE; Stamey TA
Radiology; 1987 May; 163(2):521-5. PubMed ID: 2436253
[TBL] [Abstract][Full Text] [Related]
6. Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology.
Jager GJ; Ruijter ET; van de Kaa CA; de la Rosette JJ; Oosterhof GO; Thornbury JR; Barentsz JO
AJR Am J Roentgenol; 1996 Apr; 166(4):845-52. PubMed ID: 8610561
[TBL] [Abstract][Full Text] [Related]
7. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy.
Kurhanewicz J; Vigneron DB; Nelson SJ; Hricak H; MacDonald JM; Konety B; Narayan P
Urology; 1995 Mar; 45(3):459-66. PubMed ID: 7533458
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic laser ablation of the prostate: MR appearances during and after treatment and their relation to clinical outcome.
deSouza NM; Flynn RJ; Coutts GA; Gilderdale DJ; Hall AS; Puni R; Chui M; Harris DN; Kiely EA
AJR Am J Roentgenol; 1995 Jun; 164(6):1429-34. PubMed ID: 7538727
[TBL] [Abstract][Full Text] [Related]
9. Prostatic disorders: MR imaging at 1.5 T.
Phillips ME; Kressel HY; Spritzer CE; Arger PH; Wein AJ; Marinelli D; Axel L; Gefter WB; Pollack HM
Radiology; 1987 Aug; 164(2):386-92. PubMed ID: 2440074
[TBL] [Abstract][Full Text] [Related]
10. Determining the volume of prostatic carcinoma: value of MR imaging with an external-array coil.
Sommer FG; Nghiem HV; Herfkens R; McNeal J; Low RN
AJR Am J Roentgenol; 1993 Jul; 161(1):81-6. PubMed ID: 8517328
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
Kurhanewicz J; Vigneron DB; Hricak H; Narayan P; Carroll P; Nelson SJ
Radiology; 1996 Mar; 198(3):795-805. PubMed ID: 8628874
[TBL] [Abstract][Full Text] [Related]
12. Hormonal ablation of prostatic cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging.
Chen M; Hricak H; Kalbhen CL; Kurhanewicz J; Vigneron DB; Weiss JM; Carroll PR
AJR Am J Roentgenol; 1996 May; 166(5):1157-63. PubMed ID: 8615261
[TBL] [Abstract][Full Text] [Related]
13. Pathologic characterization of human prostate tissue with proton MR spectroscopy.
Swindle P; McCredie S; Russell P; Himmelreich U; Khadra M; Lean C; Mountford C
Radiology; 2003 Jul; 228(1):144-51. PubMed ID: 12832578
[TBL] [Abstract][Full Text] [Related]
14. [Clinical use of endorectal coil MR in the study of prostatic pathology with special reference to hyperplasia and carcinoma].
Gualdi GF; Polettini E; Casciani E
Clin Ter; 1996; 147(1-2):51-66. PubMed ID: 8767956
[TBL] [Abstract][Full Text] [Related]
15. Benign prostatic hyperplasia: value of MR imaging for determining histologic type.
Ishida J; Sugimura K; Okizuka H; Kaji Y; Moriyama M; Nagaoka S; Mizutani M; Ishida T
Radiology; 1994 Feb; 190(2):329-31. PubMed ID: 7506836
[TBL] [Abstract][Full Text] [Related]
16. Noise-reduced prostatic MR imaging. Work in progress.
Sommer G; Brosnan T; Cao Q; Nishimura D; Macovski A; McNeal J
Radiology; 1988 Nov; 169(2):347-50. PubMed ID: 2459726
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma of the prostate: MR images obtained with body coils do not accurately reflect tumor volume.
Quint LE; Van Erp JS; Bland PH; Mandell SH; Del Buono EA; Grossman HB; Glazer GM; Gikas PW
AJR Am J Roentgenol; 1991 Mar; 156(3):511-6. PubMed ID: 1899746
[TBL] [Abstract][Full Text] [Related]
18. Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy.
Wang L; Mazaheri Y; Zhang J; Ishill NM; Kuroiwa K; Hricak H
Radiology; 2008 Jan; 246(1):168-76. PubMed ID: 18024440
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of transitional zone prostate cancer from benign hyperplasia nodules: evaluation of discriminant criteria at multiparametric MRI.
Chesnais AL; Niaf E; Bratan F; Mège-Lechevallier F; Roche S; Rabilloud M; Colombel M; Rouvière O
Clin Radiol; 2013 Jun; 68(6):e323-30. PubMed ID: 23528164
[TBL] [Abstract][Full Text] [Related]
20. [Magnetic resonance imaging in the diagnosis of prostatic carcinoma and benign hyperplasia].
Fujiwara K; Isaka S; Shimazaki J
Nihon Hinyokika Gakkai Zasshi; 1989 Sep; 80(9):1336-42. PubMed ID: 2480470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
